Erlotinib Terminated Phase 2 Trials for Advanced Adult Primary Liver Cancer / Adult Primary Hepatocellular Carcinoma / Localized Unresectable Adult Primary Liver Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00047333Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed